Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$1.46 - $2.45 $65,228 - $109,458
-44,677 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$2.13 - $3.46 $10,136 - $16,466
-4,759 Reduced 9.63%
44,677 $104,000
Q3 2021

Nov 15, 2021

BUY
$3.14 - $3.9 $4,813 - $5,978
1,533 Added 3.2%
49,436 $172,000
Q2 2021

Aug 17, 2021

SELL
$3.8 - $4.56 $26,508 - $31,810
-6,976 Reduced 12.71%
47,903 $186,000
Q1 2021

May 17, 2021

BUY
$4.33 - $6.63 $180,279 - $276,040
41,635 Added 314.37%
54,879 $253,000
Q4 2020

Feb 16, 2021

BUY
$4.87 - $17.29 $64,498 - $228,988
13,244 New
13,244 $80,000
Q3 2020

Nov 16, 2020

SELL
$15.08 - $27.04 $131,874 - $236,464
-8,745 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$14.57 - $23.96 $127,414 - $209,530
8,745 New
8,745 $204,000
Q1 2020

May 15, 2020

SELL
$10.27 - $21.23 $465,426 - $962,122
-45,319 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$8.36 - $23.81 $378,866 - $1.08 Million
45,319 New
45,319 $927,000

Others Institutions Holding ASMB

# of Institutions
1
Shares Held
16.3K
Call Options Held
0
Put Options Held
0

About ASSEMBLY BIOSCIENCES, INC.


  • Ticker ASMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,436,900
  • Market Cap $737M
  • Description
  • Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...
More about ASMB
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.